Investor Alert: Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of Theragenics Corporation
06 Agosto 2013 - 3:09PM
Business Wire
Holzer Holzer & Fistel, LLC is investigating whether the
directors of Theragenics Corporation (“Theragenics” or the
“Company”) (NYSE: TGX) complied with their fiduciary duties in
approving the proposed acquisition of the Company by Juniper
Investment Company. Under the proposed terms of the buyout,
Theragenics shareholders would receive $2.20 per share for each
share of TGX owned. The firm’s investigation seeks to determine,
among other things, whether the consideration to be paid to
Theragenics shareholders is fair and adequate.
Current holders of Theragenics common stock with questions
concerning their legal rights are encouraged to contact Holzer
Holzer & Fistel, LLC and its attorneys Michael I. Fistel, Jr.,
Esq. or Marshall P. Dees, Esq. via email at
mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via
toll-free telephone at (888) 508-6832.
Holzer Holzer & Fistel, LLC dedicates its practice to
vigorous representation of shareholders and investors in litigation
nationwide, including shareholder class action and derivative
litigation. More information about the firm is available through
its website, www.holzerlaw.com and upon request from the
firm. Holzer Holzer & Fistel, LLC has paid for the
dissemination of this promotional communication, and Michael I.
Fistel, Jr. is the attorney responsible for its content.
Theragenics (NYSE:TGX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Theragenics (NYSE:TGX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Theragenics Corp. da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Theragenics Corp.